BioNanoTox for all, all for BioNanoTox! Welcome! Present, publish, interact and have fun at the 6th BioNanoTox Conference! This year you will have the unique opportunity to attend our Conference.As in past years, this conference will offer outstanding national and international speakers and latest topics. There will be ample time for abstracts, posters and the many informal discussions that have helped make past meetings a success. The main aspects that make the BioNanoTox event a unique conference are: trade exhibition, education, business convention and recruitment drive. These events make it possible to bring together partners from Research, Academia, Industry, and Finance.
 La Quinta Inn & Suites, Downtown Conference Center
617 S. Broadway, Little Rock, AR 72201
Phone: 1-501-374-9000, FAX: 1-501-374-9009  Thursday, November 17th, 2011 Conference: 9:00am - 5:00pm
Reception & Award Ceremony: 6:00pm - 8:00pm
Friday, November 18th, 2011 Conference: 9:00am - 5:00pm  Early registration: June 1st - August 31st, 2011 Late registration: September 1st - October 15th, 2011
Registration closes: October 15th, 2011, at 11:59pm (CST)   Parimal Chowdhury, Ph.D. Olga Tarasenko, M.D., Ph.D. Professor (UAMS) Assistant Professor (UALR) BioNanoTox Co-Chair BioNanoTox Founder & Co-chair > See also: Organizational Committee 2011
K e y n o t e S p e a k e r s 1st Plenary Talk
Dr. Stephen Winters-Hilt has contributed to the development of HMM-based sequence analysis, nanopore detectors, and is the inventor of the nanopore transduction approach. Prof. Winters-Hilt has recently authored the book "Machine-Learning based sequence analysis, bioinformatics & nanopore transduction detection" (ISBN: 978-1-257-64525-1, June, 2011). In these endeavors, a Ph.D. (June, 1997; U. Wisc) in physics (Advisors: Leonard Parker & John Friedman), a B.S. in electrical engineering (June, 1987; Caltech), and M.S. in applied physics (June, 1990; Caltech; Advisor: Kip Thorne), were brought to bear on the device physics and electrochemistry problems encountered. In these endeavors Dr. Winters-Hilt also pursued D.Phil studies in mathematical physics at Oxford (Advisor: Sir Roger Penrose) before completing a second Ph.D. in Computer Science at UCSC in 2003 (Advisor: David Haussler), with thesis concentration in Bioinformatics and Machine Learning. Dr. Winters-Hilt is now an Associate Professor in the Computer Science Department at the University of New Orleans (UNO), and co-Founder of Meta Logos Inc., which has obtained exclusive license to the NTD intellectual property (21 patents by Dr. Winters-Hilt).
Research Interests: > Bioinformatics - gene structure identification, genomics, expression analysis 2nd Plenary Talk:
 Marina A. Dobrovolskaia, Ph.D.
"Immunological Properties of Engineered Nanomaterials"
Title of talk Marina A. Dobrovolskaia is a Senior Scientist, Nanotechnology Characterization Lab (NCL), Advanced Technology Program, SAIC-Frederick, Inc.National Cancer Institute, Frederick, Maryland, USA.
At the NCL, Dr. Dobrovolskaia directs characterization related to a nanomaterials' interaction with components of the immune system. She monitors acute/adverse effects of nanoparticles as they relate to the immune system, both in vitro and in animal models. Dr. Dobrovolskaia is also responsible for the development, validation and performance qualification of in vitro and ex vivo assays to support preclinical characterization of nanoparticles, and for monitoring nanoparticle purity from biological contaminants such as bacteria, yeast, mold and endotoxin. Additionally, she leads structure activity relationship studies aimed at identifying the relationship between nanoparticle physicochemical properties and their interaction with macrophages, components of the blood coagulation cascade, and complement systems.
Prior to joining the NCL, Dr. Dobrovolskaia worked as a Research Scientist in a GLP laboratory at PPD Development, Inc. in Richmond, VA. She was responsible for the design, development and validation of bioanalytical ligand-binding assays to support pharmacokinetic and toxicity studies in a variety of drug development projects. She received her M.S. degree from the Kazan State University in Russia, her Ph.D. from the N.N. Blokhin Cancer Research Center of the Russian Academy of Medical Sciences in Moscow, Russia, and completed two postdoctoral trainings in immunology at the National Cancer Institute in Frederick, MD and the University of Maryland in Baltimore, MD. Her areas of expertise include cell signaling, innate immunity, immunogenicity and analytical methodology.   Funding for this conference was made possible, in part, by the Food and Drug Administration through Grant # 1 R13 FD003707-01. The views expressed in written conference materials or publications and by speakers and moderators do not necessarely reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organization imply endorsement by the U.S. Government. This conference was supported by FDAIR13 FD003797. Co-Sponsors Contact BioNanoTox at (+1)501-569-3270 or bionanotox@gmail.com
Webdesign and maintenance by Guenther Duvall, Allyson Speech Labs, Brooklyn NY Forward constructive suggestions for improvements to brooklyndigest@gmail.com |
|
|
|
|
Welcome ! |
